Provided by Tiger Trade Technology Pte. Ltd.

GlucoTrack, Inc.

3.14
+0.21007.17%
Pre-market: 3.13-0.0100-0.32%06:36 EDT
Volume:58.96K
Turnover:185.79K
Market Cap:2.21M
PE:-0.03
High:3.30
Open:2.93
Low:2.93
Close:2.93
52wk High:212.10
52wk Low:2.90
Shares:705.25K
Float Shares:701.36K
Volume Ratio:0.99
T/O Rate:8.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-112.7747
EPS(LYR):-468.2383
ROE:-620.63%
ROA:-164.45%
PB:-1.27
PE(LYR):-0.01

Loading ...

GlucoTrack Issues $2 Million 5% Convertible Note to Alto Opportunity Master Fund in Settlement Deal

Reuters
·
13 hours ago

GlucoTrack Unit Lōkahi Therapeutics Expands Ai² Platform into Three Divisions

Reuters
·
Sep 08

GlucoTrack announces collaboration with SDSU Fowler College of Business

TIPRANKS
·
Sep 02

LŌKahi Therapeutics™ Expands AI² Futures Lab™ Asset Origination Network Through Collaboration with San Diego State University Fowler College of Business

THOMSON REUTERS
·
Sep 02

GlucoTrack Inc trading halted, news pending

TIPRANKS
·
Aug 29

NASDAQ Trade Halt Halt News Pending at 07:50 Pm

Reuters
·
Aug 29

GlucoTrack Amends 8-K to Add Accountant Review Report for Lokahi Interim Financials

Reuters
·
Aug 29

GlucoTrack to Enact 1-for-15 Reverse Stock Split Aug. 31

Reuters
·
Aug 27

GlucoTrack, Inc. Announces Reverse Stock Split

THOMSON REUTERS
·
Aug 27

GlucoTrack subsidiary initiates clinical trial manufacturing for LT-100

TIPRANKS
·
Aug 25

GlucoTrack Unit Lokahi Therapeutics Starts GMP Manufacturing for LT-100 Osteoarthritis Pain Candidate

Reuters
·
Aug 25

LŌKahi Therapeutics™ Initiates Clinical Trial Manufacturing for Lt-100

THOMSON REUTERS
·
Aug 25

GlucoTrack Unit Lokahi Therapeutics Expands Ai2 Futures Lab Collaboration with University of Georgia

Reuters
·
Aug 21

LŌKahi Therapeutics™ Expands AI² Futures Lab™ Asset Origination Network Through Continued Collaboration with the University of Georgia

THOMSON REUTERS
·
Aug 21

GlucoTrack Holds Annual Shareholder Meeting with 36.1% of Shares Represented

Reuters
·
Aug 19

Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation

Reuters
·
Aug 17

Glucotrack Regains NASDAQ Stockholders’ Equity Compliance, Secures Continued Listing

Reuters
·
Aug 17

GlucoTrack Achieves Key Compliance Milestone and Advances Strategic Transformation

THOMSON REUTERS
·
Aug 17

GlucoTrack FY26 Q2 Net Loss Narrows 19.8% to USD 3.81 Million

Reuters
·
Aug 15

GlucoTrack Announces Special Shareholder Meeting

Reuters
·
Aug 11